31 filings
Page 2 of 2
8-K
7lei3u
1 Aug 19
Eidos Therapeutics Reports Second Quarter 2019 Financial Results
4:31pm
8-K
24g7ri 47ncdfn7p
17 Jun 19
Departure of Directors or Certain Officers
4:03pm
8-K
x45107pjv7wcc6mw2e
7 May 19
Eidos Therapeutics Reports First Quarter 2019 Financial Results
4:30pm
8-K
ihn1f objq
15 Apr 19
Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
8:30am
8-K
jgjjss qum0e
1 Apr 19
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:06pm
8-K
lvzcs5co1
27 Feb 19
Other Events
7:00am
8-K
6hn si6ww6vot
21 Feb 19
Changes in Registrant's Certifying Accountant
9:00am
8-K
mt3ba9hzos5scleldk
6 Dec 18
Eidos Therapeutics Appoints William Lis to Board of Directors
4:15pm
8-K
wydd9l
13 Nov 18
Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in Symptomatic Patients with Mutant or Wild-Type TTR Amyloid Cardiomyopathy
6:05am
8-K
lgoi0rvu0wtnzfdrj 1q
6 Nov 18
Results of Operations and Financial Condition
4:30pm
8-K
vxuolhl
7 Aug 18
Results of Operations and Financial Condition
12:00am